{"id": "1338437503699873792", "creation": 1607943342.0, "user_id": "989045379445510145", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 23, "reply_count": 6, "like_count": 99, "quote_count": 12}}, "text": "We are fulfilling our mission of revolutionizing RNA for life - every life. Today, we initiated HERALD, our global pivotal Phase 2b/3 trial to assess the safety and efficacy of #CVnCoV, our #mRNA #vaccine candidate against #COVID19 \nhttps://t.co/Te5HVggacd https://t.co/xYw730uGpb", "first_save": 1634559108.199414, "hashtags": ["#CVNCOV", "#MRNA", "#VACCINE", "#COVID19"]}